...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Feb. 06, 2019 FMV ZENE!
2
Feb 07, 2019 12:11PM
3
Feb 07, 2019 01:14PM

I dont see an open market for ZENE shares..is there one??.....if not I assume we have to use the Fair Value as Fair Market Value in this case. When speaking with Revenue Canada I discussed this point. They noted that it is the audited financials which shows the equity and again which would have to be used in transacting shares since no open market exists. 

Have you discussed this point with Revenue Canada?

2
Feb 07, 2019 02:09PM
2
Feb 07, 2019 02:42PM
2
Feb 07, 2019 02:59PM
1
Feb 07, 2019 03:18PM
1
Feb 07, 2019 03:55PM
2
Feb 07, 2019 04:13PM
3
Feb 07, 2019 05:50PM
2
Feb 07, 2019 05:57PM
Share
New Message
Please login to post a reply